Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains

被引:0
作者
Jinuk Kim
Wonhee Han
Taeyong Park
Eun Jin Kim
Injin Bang
Hyun Sik Lee
Yejin Jeong
Kyeonghwan Roh
Jeesoo Kim
Jong-Seo Kim
Chanhee Kang
Chaok Seok
Jin-Kwan Han
Hee-Jung Choi
机构
[1] Seoul National University,Department of Biological Sciences
[2] Pohang University of Science and Technology,Department of Life Sciences
[3] Seoul National University,Department of Chemistry
[4] Sungkyunkwan University,School of Pharmacy
[5] Center for RNA Research,Department of Physiology and Cellular Biophysics
[6] Institute for Basic Science,undefined
[7] Plumbline Life Sciences,undefined
[8] Inc.,undefined
[9] Columbia University Irving Medical Center,undefined
来源
Nature Communications | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Low-density lipoprotein receptor-related protein 6 (LRP6) is a coreceptor of the β-catenin-dependent Wnt signaling pathway. The LRP6 ectodomain binds Wnt proteins, as well as Wnt inhibitors such as sclerostin (SOST), which negatively regulates Wnt signaling in osteocytes. Although LRP6 ectodomain 1 (E1) is known to interact with SOST, several unresolved questions remain, such as the reason why SOST binds to LRP6 E1E2 with higher affinity than to the E1 domain alone. Here, we present the crystal structure of the LRP6 E1E2–SOST complex with two interaction sites in tandem. The unexpected additional binding site was identified between the C-terminus of SOST and the LRP6 E2 domain. This interaction was confirmed by in vitro binding and cell-based signaling assays. Its functional significance was further demonstrated in vivo using Xenopus laevis embryos. Our results provide insights into the inhibitory mechanism of SOST on Wnt signaling.
引用
收藏
相关论文
共 64 条
[1]  
Cheng Z(2011)Crystal structures of the extracellular domain of LRP6 and its complex with DKK1 Nat. Struct. Mol. Biol. 18 1204-1210
[2]  
Bourhis E(2010)Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6 J. Biol. Chem. 285 9172-9179
[3]  
Semenov M(2005)SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor J. Biol. Chem. 280 26770-26775
[4]  
Tamai K(2011)Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6 Dev. Cell 21 862-873
[5]  
He X(2009)Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals J. Biol. Chem. 284 23159-23168
[6]  
Ahn VE(2001)Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein Am. J. Hum. Genet 68 577-589
[7]  
Lintern KB(2001)Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Hum. Mol. Genet. 10 537-543
[8]  
Guidato S(2003)Osteocyte control of bone formation via sclerostin, a novel BMP antagonist EMBO J. 22 6267-6276
[9]  
Rowe A(2008)Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength J. Bone Min. Res. 23 860-869
[10]  
Saldanha JW(2006)LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST J. Biol. Chem. 281 38276-38284